This inventor holds 1 USPTO granted patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Yannick Debing: Inventor in Nucleoside Analogs
Introduction
Yannick Debing is an inventor based in Beerse, Belgium. His patent work includes research into nucleoside analogs for the treatment of hepatitis E. He is associated with Janssen Pharmaceutica NV and has 1 patent listed in the information provided.
Latest Patents
Debing’s listed patent is “Bi- and Monocyclic Nucleoside Analogs for Treatment of Hepatitis E.” The invention concerns nucleoside analogs investigated for their potential use against hepatitis E.
Career Highlights
Debing’s recorded patent activity reflects work in pharmaceutical research and the development of potential treatments for infectious disease. His listed company affiliation is Janssen Pharmaceutica NV.
Collaborations
The provided information names Tim Hugo Maria Jonckers and Frederik Pauwels as coworkers. Their names appear alongside Debing’s work on the listed patent.
Conclusion
Yannick Debing’s patent record highlights his contribution to pharmaceutical innovation through research on nucleoside analogs for hepatitis E treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile